Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.

Subjects

Subjects :

Bortezomib
Clinical Trials as Topic
Health Knowledge, Attitudes, Practice
Humans
Internet
Japan
Lung Diseases chemically induced
Newspapers as Topic
Patient Selection
Periodicals as Topic
Practice Guidelines as Topic
Risk Assessment
Societies, Medical
Antineoplastic Agents adverse effects
Boronic Acids adverse effects
Cooperative Behavior
Drug Industry
Interdisciplinary Communication
Lung Diseases prevention & control
Mass Media
Medical Staff
Multiple Myeloma drug therapy
Pyrazines adverse effects

Details

Language :

English

ISSN :

1527-7755

Volume :

26

Issue :

35

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Report

Accession number :

19001340

Full Text :

https://doi.org/10.1200/JCO.2008.20.3307